Chong Kun Im

648 total citations
11 papers, 520 citations indexed

About

Chong Kun Im is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Chong Kun Im has authored 11 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Chong Kun Im's work include Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Chong Kun Im is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Chong Kun Im collaborates with scholars based in South Korea, United States and Canada. Chong Kun Im's co-authors include Hyun Cheol Chung, Sun Young Rha, Hei‐Cheul Jeung, Joong Bae Ahn, Sung Hoon Noh, Jae Kyung Roh, Hye Ryun Kim, Jieun Roh, Sung‐Moo Kim and Seong Ha Cheon and has published in prestigious journals such as Cancer, Journal of Hepatology and Annals of Oncology.

In The Last Decade

Chong Kun Im

11 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chong Kun Im South Korea	9	232	215	136	131	125	11	520
Ayumu Hosokawa Japan	14	273 1.2×	225 1.0×	167 1.2×	63 0.5×	141 1.1×	89	554
Yasushi Mochida Japan	14	224 1.0×	90 0.4×	333 2.4×	156 1.2×	146 1.2×	38	670
Isac I. Schnirer United States	9	270 1.2×	256 1.2×	270 2.0×	73 0.6×	157 1.3×	10	560
Tokuhiro Matsubara Japan	14	172 0.7×	92 0.4×	92 0.7×	140 1.1×	105 0.8×	28	510
M. Lorenz Germany	8	421 1.8×	228 1.1×	143 1.1×	169 1.3×	26 0.2×	20	620
Eiichiro Yumoto Japan	10	54 0.2×	106 0.5×	168 1.2×	126 1.0×	104 0.8×	13	455
Charlotte Mussini France	11	488 2.1×	89 0.4×	107 0.8×	40 0.3×	215 1.7×	36	702
Alexandra Heurgué France	7	153 0.7×	85 0.4×	101 0.7×	322 2.5×	174 1.4×	17	506
Giacomo Batignani Italy	14	340 1.5×	79 0.4×	294 2.2×	253 1.9×	300 2.4×	32	690
T.C. Kok Netherlands	13	125 0.5×	217 1.0×	266 2.0×	85 0.6×	90 0.7×	20	490

Countries citing papers authored by Chong Kun Im

Since Specialization

Citations

This map shows the geographic impact of Chong Kun Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Kun Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Kun Im more than expected).

Fields of papers citing papers by Chong Kun Im

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong Kun Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Kun Im. The network helps show where Chong Kun Im may publish in the future.

Co-authorship network of co-authors of Chong Kun Im

This figure shows the co-authorship network connecting the top 25 collaborators of Chong Kun Im. A scholar is included among the top collaborators of Chong Kun Im based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong Kun Im. Chong Kun Im is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Kim, Moon Young, Mee-Yon Cho, Soon Koo Baik, et al.. (2011). Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. Journal of Hepatology. 55(5). 1004–1009. 127 indexed citations

Jeung, Hei‐Cheul, Sun Young Rha, Chong Kun Im, et al.. (2010). A randomized phase 2 study of docetaxel and S‐1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy. Cancer. 117(10). 2050–2057. 39 indexed citations

Im, Chong Kun, Sun Young Rha, Hei‐Cheul Jeung, et al.. (2010). A Phase II Study of a Combined Biweekly Irinotecan and Monthly Cisplatin Treatment for Metastatic or Recurrent Gastric Cancer. American Journal of Clinical Oncology. 33(1). 56–60. 3 indexed citations

Chang, Hyun, Sun Young Rha, Chong Kun Im, et al.. (2010). Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy.. PubMed. 23(1). 271–8. 37 indexed citations

Im, Chong Kun, Sun Young Rha, Hei‐Cheul Jeung, et al.. (2009). A Phase II Feasibility Study of Weekly Paclitaxel in Heavily Pretreated Advanced Gastric Cancer Patients with Poor Performance Status. Oncology. 77(6). 349–357. 5 indexed citations

Chon, Hong Jae, Sun Young Rha, Chong Kun Im, et al.. (2009). Docetaxel versus Paclitaxel Combined with 5-FU and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials. Cancer Research and Treatment. 41(4). 196–196. 23 indexed citations

Chang, Hsin Wen, Sun Young Rha, Hei‐Cheul Jeung, et al.. (2009). Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients. 20(2). 272–277. 12 indexed citations

Cheon, Seong Ha, Sun Young Rha, Hei‐Cheul Jeung, et al.. (2008). Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Annals of Oncology. 19(6). 1146–1153. 145 indexed citations

Chang, Hang‐Seok, Sun Young Rha, Hei‐Cheul Jeung, et al.. (2008). Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients. Annals of Oncology. 20(2). 272–277. 93 indexed citations

10.

Jeong, Jae-Heon, Hei‐Cheul Jeung, Sun Young Rha, et al.. (2008). Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer. Annals of Oncology. 19(6). 1135–1140. 21 indexed citations

11.

Im, Chong Kun, Hei‐Cheul Jeung, Sun Young Rha, et al.. (2007). A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 61(2). 315–321. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact